IGI Inc. (IG)


IGI offers its proprietary Novasome® lipid vesicle encapsulation technology for use in delivering solutions to the dermatological, consumer, skin care and hair care markets, by our Consumer Products Division and by other leading companies that license IGI's technologies for use in their own products. IGI is committed to using the Novasome® technology to solve problems in the performance, quality and efficacy of a wide range of products in diverse industries. IGI's solutions are based on the patented Novasome® micro-encapsulation technology - offering a host of unique benefits to companies that mix or combine ingredients to produce their products. The Novasome® technology has many advantages, as it can be applied to medicines, cosmetics, skin care products, chemicals, biocides, pesticides, fuels, foods, beverages, petcare supplies and other products. The capability for IGI to broadly leverage Novasomes® uniquely to meet the needs of a wide range of customers positions IGI for the millenium.

Contact Information

105 Lincoln Avenue
Buena, NJ 08310

tel: 856-697-1441
fax: 856-697-1001


Investor Relations



Exchange: AMEX
Industry: Biotechnology
Market Cap: $36.3M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.